- Ars Live: Join america Tuesday arsenic we sermon GLP-1 drugs—insights and unknowns Ars Technica
- GLP-1s similar Ozempic are among the astir important cause breakthroughs ever The Economist
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists successful the Management of Type 2 Diabetes and Associated Metabolic Disorders Cureus
- Exclusive Physician Survey Results connected GLP-1 Receptor Agonists: The Hype Is Real Patient Care Online
- GLP–1s: A Healthcare Revolution? Ipsos successful Canada